Circulating cell-free DNA integrity as a diagnostic and prognostic marker for breast and prostate cancers
The incidence of cancer and its related mortality is on the rise and has become a major public health concern. Currently, it is the second leading cause of death globally and was responsible for about 8.82 million deaths in, 2015 [1]. The international Agency for Research on Cancers of the WHO in 2012 projected that by the year 2030, there would be approximately 21.7 million new cancer cases and 13 million cancer deaths globally due to population growth and increased life expectancy [2]. Cancer incidence and mortality over the years have also seen a steady rise on the African continent with breast and prostate cancers among the leading causes of cancer deaths in females and males, respectively [1,3].
Source: Cancer Genetics and Cytogenetics - Category: Genetics & Stem Cells Authors: Benjamin Arko-Boham, Nii Ayite Aryee, Richard Michael Blay, Ewurama Dedea Ampadu Owusu, Emmanuel Ayitey Tagoe, Eshirow-Sam Doris Shackie, Ama Boatemaa Debrah, Armah Nii Adu-Aryee Tags: Original Article Source Type: research
More News: African Health | Cancer | Cancer & Oncology | Genetics | International Medicine & Public Health | Prostate Cancer